Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.
about
Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat modelsBiodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins.Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro.Excretion and toxicity evaluation of 131I-Sennoside A as a necrosis-avid agent.Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs.Evaluation of a metalloporphyrin (THPPMnCl) for necrosis-affinity in rat models of necrosis.
P2860
Q35077659-B6FD6CEA-22FD-4F08-AA2D-AD297E0CFAB4Q35987317-3A885260-A4CC-40D3-90F2-D1C8B304E79DQ36613314-BDB52F32-3302-4647-A5E4-6898A6F7620FQ36619078-8B977234-541B-44EB-B5D7-54CD53FBA843Q37071343-7FB710DE-3085-4679-954F-88C5F77527FFQ38921976-389FE36E-605E-477F-B9F8-B11A24AF5600Q38981533-F18CAF6C-18D0-42F4-BC26-A489A91982D9Q39009629-FDA3E6A8-61B0-480A-B8D3-F956AB4FE5FCQ39199545-58EB00E3-FF20-4662-9EE9-B77C38E685A1Q48286237-A49BE0D0-E497-461F-A6DA-0377BBED6CE3Q52659819-457AB00F-39B8-443F-AC9F-7A9D4CD29D9D
P2860
Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@ast
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@en
type
label
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@ast
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@en
prefLabel
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@ast
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@en
P2093
P2860
P356
P1433
P1476
Small Molecule Sequential Dual ...... nical Anticancer Applications.
@en
P2093
Alfons Verbruggen
Raymond Oyen
Yicheng Ni
P2860
P304
P356
10.7150/JCA.5635
P577
2013-01-22T00:00:00Z